nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—CHRM3—muscle of abdomen—Crohn's disease	0.0444	0.206	CbGeAlD
Methotrimeprazine—HTR2A—enteric nervous system—Crohn's disease	0.0416	0.193	CbGeAlD
Methotrimeprazine—HTR2A—myenteric nerve plexus—Crohn's disease	0.0315	0.146	CbGeAlD
Methotrimeprazine—Mepyramine—SLC22A4—Crohn's disease	0.0125	0.401	CrCbGaD
Methotrimeprazine—CHRM5—epithelium—Crohn's disease	0.00945	0.0439	CbGeAlD
Methotrimeprazine—Mepyramine—SLC22A5—Crohn's disease	0.00939	0.301	CrCbGaD
Methotrimeprazine—CHRM5—skin of body—Crohn's disease	0.00899	0.0417	CbGeAlD
Methotrimeprazine—ADRA1D—epithelium—Crohn's disease	0.00845	0.0392	CbGeAlD
Methotrimeprazine—DRD5—lymphoid tissue—Crohn's disease	0.00811	0.0377	CbGeAlD
Methotrimeprazine—CHRM3—smooth muscle tissue—Crohn's disease	0.00509	0.0236	CbGeAlD
Methotrimeprazine—ADRA1A—epithelium—Crohn's disease	0.00485	0.0225	CbGeAlD
Methotrimeprazine—CHRM3—digestive system—Crohn's disease	0.00402	0.0187	CbGeAlD
Methotrimeprazine—ADRA2C—mammalian vulva—Crohn's disease	0.00401	0.0186	CbGeAlD
Methotrimeprazine—HRH1—epithelium—Crohn's disease	0.00376	0.0174	CbGeAlD
Methotrimeprazine—ADRA1A—lymphoid tissue—Crohn's disease	0.00374	0.0173	CbGeAlD
Methotrimeprazine—HRH1—smooth muscle tissue—Crohn's disease	0.00362	0.0168	CbGeAlD
Methotrimeprazine—Imipramine—SLC22A4—Crohn's disease	0.00344	0.11	CrCbGaD
Methotrimeprazine—HRH1—mammalian vulva—Crohn's disease	0.00326	0.0151	CbGeAlD
Methotrimeprazine—ADRA2A—mammalian vulva—Crohn's disease	0.0032	0.0149	CbGeAlD
Methotrimeprazine—HTR2A—epithelium—Crohn's disease	0.00314	0.0146	CbGeAlD
Methotrimeprazine—CYP1A2—digestive system—Crohn's disease	0.00305	0.0142	CbGeAlD
Methotrimeprazine—HTR2A—smooth muscle tissue—Crohn's disease	0.00302	0.014	CbGeAlD
Methotrimeprazine—HRH1—digestive system—Crohn's disease	0.00286	0.0133	CbGeAlD
Methotrimeprazine—CYP2E1—lymphoid tissue—Crohn's disease	0.00278	0.0129	CbGeAlD
Methotrimeprazine—CYP2E1—digestive system—Crohn's disease	0.00275	0.0127	CbGeAlD
Methotrimeprazine—HTR2A—digestive system—Crohn's disease	0.00239	0.0111	CbGeAlD
Methotrimeprazine—CYP2D6—digestive system—Crohn's disease	0.00217	0.0101	CbGeAlD
Methotrimeprazine—ADRA2C—lymph node—Crohn's disease	0.00201	0.00933	CbGeAlD
Methotrimeprazine—HRH1—lymph node—Crohn's disease	0.00163	0.00758	CbGeAlD
Methotrimeprazine—ADRA2A—lymph node—Crohn's disease	0.0016	0.00744	CbGeAlD
Methotrimeprazine—Acepromazine—ALB—Crohn's disease	0.00138	0.0444	CrCbGaD
Methotrimeprazine—Thioproperazine—ALB—Crohn's disease	0.00135	0.0434	CrCbGaD
Methotrimeprazine—Pipotiazine—ALB—Crohn's disease	0.00133	0.0427	CrCbGaD
Methotrimeprazine—Clomipramine—ALB—Crohn's disease	0.00105	0.0337	CrCbGaD
Methotrimeprazine—Chlorpromazine—ALB—Crohn's disease	0.000721	0.0231	CrCbGaD
Methotrimeprazine—CHRM2—Signaling Pathways—RIPK2—Crohn's disease	0.000108	0.000144	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—SMAD3—Crohn's disease	0.000108	0.000143	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—SMAD3—Crohn's disease	0.000108	0.000143	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—RIPK2—Crohn's disease	0.000108	0.000143	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—TYK2—Crohn's disease	0.000108	0.000143	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IL3—Crohn's disease	0.000107	0.000143	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—TYK2—Crohn's disease	0.000107	0.000143	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IL3—Crohn's disease	0.000107	0.000142	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IL3—Crohn's disease	0.000107	0.000142	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IL3—Crohn's disease	0.000107	0.000141	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—GPX4—Crohn's disease	0.000106	0.000141	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—IL2RA—Crohn's disease	0.000106	0.000141	CbGpPWpGaD
Methotrimeprazine—ADRA2C—GPCR downstream signaling—JAK2—Crohn's disease	0.000106	0.00014	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—RASGRP1—Crohn's disease	0.000106	0.00014	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IL3—Crohn's disease	0.000106	0.00014	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—SOCS1—Crohn's disease	0.000105	0.00014	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—CXCL8—Crohn's disease	0.000105	0.00014	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IL3—Crohn's disease	0.000105	0.00014	CbGpPWpGaD
Methotrimeprazine—ADRA1B—GPCR downstream signaling—JAK2—Crohn's disease	0.000104	0.000138	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	0.000104	0.000138	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—CXCL8—Crohn's disease	0.000104	0.000138	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—CXCL8—Crohn's disease	0.000104	0.000138	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—SOCS1—Crohn's disease	0.000104	0.000138	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—RASGRP1—Crohn's disease	0.000104	0.000138	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—TYK2—Crohn's disease	0.000103	0.000137	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—UBE2D1—Crohn's disease	0.000103	0.000137	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—RASGRP1—Crohn's disease	0.000103	0.000137	CbGpPWpGaD
Methotrimeprazine—ADRA2B—GPCR downstream signaling—CXCL8—Crohn's disease	0.000103	0.000137	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—RASGRP1—Crohn's disease	0.000103	0.000137	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—GCKR—Crohn's disease	0.000103	0.000136	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—JAK2—Crohn's disease	0.000103	0.000136	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—JAK2—Crohn's disease	0.000103	0.000136	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—RASGRP1—Crohn's disease	0.000102	0.000135	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—RASGRP1—Crohn's disease	0.000102	0.000135	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—IL2RA—Crohn's disease	0.000101	0.000135	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—TYK2—Crohn's disease	0.000101	0.000134	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—RIPK2—Crohn's disease	0.0001	0.000133	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—IL2RA—Crohn's disease	0.0001	0.000133	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—IL2RA—Crohn's disease	0.0001	0.000133	CbGpPWpGaD
Methotrimeprazine—HTR2C—GPCR downstream signaling—CXCL8—Crohn's disease	9.92e-05	0.000132	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—TYK2—Crohn's disease	9.9e-05	0.000131	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—JAK2—Crohn's disease	9.87e-05	0.000131	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IL3—Crohn's disease	9.78e-05	0.00013	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—SMAD3—Crohn's disease	9.75e-05	0.000129	CbGpPWpGaD
Methotrimeprazine—ADRA2C—GPCR downstream signaling—CXCL8—Crohn's disease	9.64e-05	0.000128	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—JAK2—Crohn's disease	9.6e-05	0.000127	CbGpPWpGaD
Methotrimeprazine—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	9.59e-05	0.000127	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—SOCS1—Crohn's disease	9.57e-05	0.000127	CbGpPWpGaD
Methotrimeprazine—ADRA1B—GPCR downstream signaling—CXCL8—Crohn's disease	9.49e-05	0.000126	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—RASGRP1—Crohn's disease	9.46e-05	0.000126	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—JAK2—Crohn's disease	9.44e-05	0.000125	CbGpPWpGaD
Methotrimeprazine—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	9.43e-05	0.000125	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	9.42e-05	0.000125	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR downstream signaling—JAK2—Crohn's disease	9.41e-05	0.000125	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—SOCS1—Crohn's disease	9.4e-05	0.000125	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR downstream signaling—JAK2—Crohn's disease	9.38e-05	0.000125	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—CXCL8—Crohn's disease	9.38e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—SOCS1—Crohn's disease	9.37e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—SMAD3—Crohn's disease	9.36e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—CXCL8—Crohn's disease	9.36e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR downstream signaling—JAK2—Crohn's disease	9.35e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—SOCS1—Crohn's disease	9.34e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR downstream signaling—JAK2—Crohn's disease	9.26e-05	0.000123	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—SOCS1—Crohn's disease	9.25e-05	0.000123	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	9.24e-05	0.000123	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	9.22e-05	0.000122	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—TYK2—Crohn's disease	9.13e-05	0.000121	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—SMAD3—Crohn's disease	9.11e-05	0.000121	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IL2RA—Crohn's disease	9.03e-05	0.00012	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—CXCL8—Crohn's disease	9e-05	0.00012	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	8.98e-05	0.000119	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—SMAD3—Crohn's disease	8.96e-05	0.000119	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—TYK2—Crohn's disease	8.96e-05	0.000119	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—TYK2—Crohn's disease	8.93e-05	0.000119	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—TYK2—Crohn's disease	8.9e-05	0.000118	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling by GPCR—IL6—Crohn's disease	8.9e-05	0.000118	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—TYK2—Crohn's disease	8.82e-05	0.000117	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	8.79e-05	0.000117	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—CXCL8—Crohn's disease	8.76e-05	0.000116	CbGpPWpGaD
Methotrimeprazine—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	8.75e-05	0.000116	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—JAK2—Crohn's disease	8.71e-05	0.000116	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IL2RA—Crohn's disease	8.67e-05	0.000115	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—CXCL8—Crohn's disease	8.62e-05	0.000114	CbGpPWpGaD
Methotrimeprazine—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	8.61e-05	0.000114	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR downstream signaling—CXCL8—Crohn's disease	8.59e-05	0.000114	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—JAK2—Crohn's disease	8.58e-05	0.000114	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—SOCS1—Crohn's disease	8.57e-05	0.000114	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	8.57e-05	0.000114	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR downstream signaling—CXCL8—Crohn's disease	8.56e-05	0.000114	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—JAK2—Crohn's disease	8.55e-05	0.000113	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR downstream signaling—CXCL8—Crohn's disease	8.54e-05	0.000113	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—JAK2—Crohn's disease	8.52e-05	0.000113	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—JAK2—Crohn's disease	8.49e-05	0.000113	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR downstream signaling—CXCL8—Crohn's disease	8.45e-05	0.000112	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IL2RA—Crohn's disease	8.43e-05	0.000112	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	8.43e-05	0.000112	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—JAK2—Crohn's disease	8.41e-05	0.000112	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	8.39e-05	0.000111	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IL2RA—Crohn's disease	8.3e-05	0.00011	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—SMAD3—Crohn's disease	8.26e-05	0.00011	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—TYK2—Crohn's disease	8.17e-05	0.000108	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	8.13e-05	0.000108	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—SMAD3—Crohn's disease	8.11e-05	0.000108	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—SMAD3—Crohn's disease	8.09e-05	0.000107	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—SMAD3—Crohn's disease	8.06e-05	0.000107	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—SMAD3—Crohn's disease	7.98e-05	0.000106	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	7.96e-05	0.000106	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	7.95e-05	0.000105	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—TYK2—Crohn's disease	7.93e-05	0.000105	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—CXCL8—Crohn's disease	7.83e-05	0.000104	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—TYK2—Crohn's disease	7.83e-05	0.000104	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	7.82e-05	0.000104	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—CXCL8—Crohn's disease	7.8e-05	0.000104	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—JAK2—Crohn's disease	7.79e-05	0.000103	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—CXCL8—Crohn's disease	7.78e-05	0.000103	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—CXCL8—Crohn's disease	7.75e-05	0.000103	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—CXCL8—Crohn's disease	7.68e-05	0.000102	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	7.66e-05	0.000102	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IL2RA—Crohn's disease	7.65e-05	0.000102	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—JAK2—Crohn's disease	7.57e-05	0.0001	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	7.53e-05	9.99e-05	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—STAT3—Crohn's disease	7.53e-05	9.99e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IL2RA—Crohn's disease	7.51e-05	9.97e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—TYK2—Crohn's disease	7.49e-05	9.95e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IL2RA—Crohn's disease	7.49e-05	9.94e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IL2RA—Crohn's disease	7.47e-05	9.91e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—JAK2—Crohn's disease	7.47e-05	9.91e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—SMAD3—Crohn's disease	7.4e-05	9.82e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IL2RA—Crohn's disease	7.39e-05	9.81e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	7.37e-05	9.79e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	7.34e-05	9.74e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—ALB—Crohn's disease	7.29e-05	9.68e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—JAK2—Crohn's disease	7.15e-05	9.49e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—TYK2—Crohn's disease	7.14e-05	9.48e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—CXCL8—Crohn's disease	7.11e-05	9.44e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—TYK2—Crohn's disease	7.05e-05	9.35e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—TYK2—Crohn's disease	7.05e-05	9.35e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—CXCL8—Crohn's disease	6.91e-05	9.17e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IL2RA—Crohn's disease	6.85e-05	9.09e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—CXCL8—Crohn's disease	6.81e-05	9.04e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—JAK2—Crohn's disease	6.81e-05	9.04e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—JAK2—Crohn's disease	6.72e-05	8.92e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—JAK2—Crohn's disease	6.72e-05	8.92e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling by GPCR—IL6—Crohn's disease	6.57e-05	8.72e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—CXCL8—Crohn's disease	6.53e-05	8.66e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—IL6—Crohn's disease	6.48e-05	8.6e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—ALB—Crohn's disease	6.45e-05	8.57e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	6.42e-05	8.53e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—PTGS2—Crohn's disease	6.38e-05	8.47e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—TYK2—Crohn's disease	6.36e-05	8.44e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—CXCL8—Crohn's disease	6.22e-05	8.25e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—IL6—Crohn's disease	6.2e-05	8.24e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—CXCL8—Crohn's disease	6.13e-05	8.14e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—CXCL8—Crohn's disease	6.13e-05	8.14e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—TYK2—Crohn's disease	6.11e-05	8.11e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—JAK2—Crohn's disease	6.07e-05	8.05e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TYK2—Crohn's disease	5.94e-05	7.89e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—ALB—Crohn's disease	5.92e-05	7.86e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—IL6—Crohn's disease	5.91e-05	7.85e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TYK2—Crohn's disease	5.85e-05	7.76e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—IL6—Crohn's disease	5.83e-05	7.74e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—IL6—Crohn's disease	5.83e-05	7.74e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—JAK2—Crohn's disease	5.83e-05	7.74e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—JAK2—Crohn's disease	5.67e-05	7.52e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—PTGS2—Crohn's disease	5.65e-05	7.5e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—JAK2—Crohn's disease	5.58e-05	7.4e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—STAT3—Crohn's disease	5.55e-05	7.37e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—CXCL8—Crohn's disease	5.54e-05	7.35e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—STAT3—Crohn's disease	5.48e-05	7.27e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—ALB—Crohn's disease	5.44e-05	7.22e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TYK2—Crohn's disease	5.39e-05	7.16e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CXCL8—Crohn's disease	5.32e-05	7.06e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TYK2—Crohn's disease	5.31e-05	7.04e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TYK2—Crohn's disease	5.29e-05	7.03e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TYK2—Crohn's disease	5.28e-05	7e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—IL6—Crohn's disease	5.27e-05	6.99e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TYK2—Crohn's disease	5.26e-05	6.98e-05	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—IL6—Crohn's disease	5.26e-05	6.98e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—STAT3—Crohn's disease	5.25e-05	6.96e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TYK2—Crohn's disease	5.21e-05	6.91e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	5.19e-05	6.89e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PTGS2—Crohn's disease	5.18e-05	6.88e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CXCL8—Crohn's disease	5.17e-05	6.87e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—JAK2—Crohn's disease	5.14e-05	6.83e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CXCL8—Crohn's disease	5.09e-05	6.76e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—JAK2—Crohn's disease	5.06e-05	6.72e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—IL6—Crohn's disease	5.06e-05	6.71e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—JAK2—Crohn's disease	5.05e-05	6.7e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—JAK2—Crohn's disease	5.03e-05	6.68e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—JAK2—Crohn's disease	5.02e-05	6.66e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—STAT3—Crohn's disease	5e-05	6.64e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—JAK2—Crohn's disease	4.97e-05	6.6e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	4.96e-05	6.58e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—STAT3—Crohn's disease	4.93e-05	6.55e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—STAT3—Crohn's disease	4.93e-05	6.55e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—IL6—Crohn's disease	4.92e-05	6.53e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—IL6—Crohn's disease	4.84e-05	6.43e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TYK2—Crohn's disease	4.83e-05	6.41e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PTGS2—Crohn's disease	4.76e-05	6.32e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CXCL8—Crohn's disease	4.69e-05	6.23e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	4.62e-05	6.13e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CXCL8—Crohn's disease	4.61e-05	6.12e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—JAK2—Crohn's disease	4.6e-05	6.11e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CXCL8—Crohn's disease	4.59e-05	6.1e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CXCL8—Crohn's disease	4.58e-05	6.08e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CXCL8—Crohn's disease	4.54e-05	6.02e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	4.52e-05	6e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—IL6—Crohn's disease	4.46e-05	5.92e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—STAT3—Crohn's disease	4.45e-05	5.91e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—IL6—Crohn's disease	4.39e-05	5.83e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—IL6—Crohn's disease	4.38e-05	5.82e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—IL6—Crohn's disease	4.37e-05	5.8e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—IL6—Crohn's disease	4.35e-05	5.78e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—IL6—Crohn's disease	4.31e-05	5.72e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	4.3e-05	5.71e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—STAT3—Crohn's disease	4.28e-05	5.68e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CXCL8—Crohn's disease	4.2e-05	5.58e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—STAT3—Crohn's disease	4.16e-05	5.52e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—STAT3—Crohn's disease	4.09e-05	5.43e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—IL6—Crohn's disease	4e-05	5.3e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—IL6—Crohn's disease	3.88e-05	5.15e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—ALB—Crohn's disease	3.86e-05	5.12e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—IL6—Crohn's disease	3.83e-05	5.08e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—STAT3—Crohn's disease	3.78e-05	5.01e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—STAT3—Crohn's disease	3.71e-05	4.93e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—STAT3—Crohn's disease	3.71e-05	4.92e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—STAT3—Crohn's disease	3.69e-05	4.9e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—STAT3—Crohn's disease	3.68e-05	4.89e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—IL6—Crohn's disease	3.67e-05	4.86e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—STAT3—Crohn's disease	3.65e-05	4.84e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	3.64e-05	4.83e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—IL6—Crohn's disease	3.49e-05	4.64e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—IL6—Crohn's disease	3.45e-05	4.57e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—IL6—Crohn's disease	3.45e-05	4.57e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—STAT3—Crohn's disease	3.38e-05	4.49e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PTGS2—Crohn's disease	3.38e-05	4.48e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—ALB—Crohn's disease	3.27e-05	4.34e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IL6—Crohn's disease	3.11e-05	4.13e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IL6—Crohn's disease	2.99e-05	3.97e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IL6—Crohn's disease	2.91e-05	3.86e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PTGS2—Crohn's disease	2.86e-05	3.8e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IL6—Crohn's disease	2.86e-05	3.8e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IL6—Crohn's disease	2.64e-05	3.5e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IL6—Crohn's disease	2.59e-05	3.44e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IL6—Crohn's disease	2.59e-05	3.44e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IL6—Crohn's disease	2.58e-05	3.43e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IL6—Crohn's disease	2.57e-05	3.41e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IL6—Crohn's disease	2.55e-05	3.38e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IL6—Crohn's disease	2.54e-05	3.37e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IL6—Crohn's disease	2.36e-05	3.13e-05	CbGpPWpGaD
